Dallas Hankins v. Sprouting Farms Corp.

CourtIntermediate Court of Appeals of West Virginia
DecidedNovember 15, 2022
Docket22-ica-12
StatusPublished

This text of Dallas Hankins v. Sprouting Farms Corp. (Dallas Hankins v. Sprouting Farms Corp.) is published on Counsel Stack Legal Research, covering Intermediate Court of Appeals of West Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Dallas Hankins v. Sprouting Farms Corp., (W. Va. Ct. App. 2022).

Opinion

IN THE INTERMEDIATE COURT OF APPEALS OF WEST VIRGINIA

FILED DALLAS HANKINS, November 15, 2022 Claimant Below, Petitioner EDYTHE NASH GAISER, CLERK INTERMEDIATE COURT OF APPEALS

vs.) No. 22-ICA-12 (JCN: 2021013918) OF WEST VIRGINIA

SPROUTING FARMS CORP., Employer Below, Respondent

MEMORANDUM DECISION

Petitioner Dallas Hankins appeals the July 11, 2022, Order of the Workers’ Compensation Office of Judges (“OOJ”). Respondent Sprouting Farms Corp. filed a timely response. 1 Petitioner did not file a reply brief. The issues on appeal are whether the OOJ erred in affirming the claim administrator’s order dated October 6, 2021, denying the compensability of lumbar radiculopathy, and the orders dated September 9, 2021, denying authorization for a left L5-S1 lumbar transforaminal epidural steroid injection (“TESI” or “LESI”), and suspending temporary total disability (“TTD”) benefits.

This Court has jurisdiction over this appeal pursuant to West Virginia Code § 51- 11-4 (2022). After considering the parties’ arguments, the record on appeal, and the applicable law, this Court finds no substantial question of law and no prejudicial error. For these reasons, a memorandum decision affirming the OOJ’s Order is appropriate under Rule 21 of the Rules of Appellate Procedure.

Mr. Hankins injured his low back while working for Sprouting Farm Corp. on January 4, 2021, when he was lifting boxes into a truck and experienced shooting pain in his back. He subsequently filed a workers’ compensation claim related to this injury. The claim administrator held the claim compensable for a lumbar sprain/strain by order dated January 15, 2021. The order also granted TTD benefits from January 6, 2021, through January 18, 2021.

Dr. Crow, a neurosurgeon, examined Mr. Hankins on February 26, 2021. At the visit, Mr. Hankins reported intermittent back pain and left buttock pain over the last few

1 Petitioner is represented by Reginald D. Henry, Esq. Respondent is represented by Jeffrey B. Brannon, Esq. We note that the cover page of respondent’s brief lists “Insperity Services, L.P. Employer.” However, the relationship between Sprouting Farms Corp. and Insperity Services, L.P. is not explained, and the case below did not include Insperity Services, L.P. as a party, so we decline to amend the case style. 1 years, but no leg symptoms until the injury. Based on the examination and a recent MRI, Dr. Crow diagnosed back and left leg pain after a lifting injury, left L5 radiculopathy, and Grade I L5-S1 spondylolisthesis with left foraminal and lateral recess stenosis and moderately severe L4-5 disc degeneration. Dr. Crow’s treatment recommendation was a left L5 LESI and possible surgery for disc degeneration and left L5 radiculopathy. Dr. Crow kept Mr. Hankins off work until the injection was completed.

Mr. Hankins subsequently underwent three electromyography/nerve conduction studies (“EMG/NCS”) to measure the electrical activity of his muscles and nerves in his lower extremities. On March 18, 2021, Dr. Goldfarb performed the first test, which was normal and revealed no radiculopathy. A second test, the only abnormal test, was performed by Dr. Richards on May 13, 2021. Dr. Richards said the test was abnormal and suggestive of low lumbar radiculopathy. Further, Dr. Richards said EMGs may be normal in up to 30% of cases of radiculopathy. A third test conducted by Dr. Ferguson on July 29, 2021, was normal.

In a report dated August 24, 2021, Dr. Stoll issued an addendum to a previous independent medical evaluation. 2 Dr. Stoll reviewed the three EMG/NCS reports and questioned the validity of the single, abnormal test. He said the report for the abnormal test was “nonspecific and vague” as it did not mention a specific nerve root involvement. Thus, Dr. Stoll opined that it was inconsistent with the purpose of an EMG/NCS, which is to identify a specific nerve root involvement. He concluded that the testing did not support a diagnosis of lumbar radiculopathy.

Dr. Stoll then compared imaging studies that included MRIs and x-rays dated 2003, 2017, and 2021, and determined that they revealed a natural, age-related progression of preexisting lumbar spondylosis and spondylolysis. Based upon this and his conclusion from the EMG/NCS testing, he recommended that the claim administrator deny Dr. Crow’s request for a lumbar TESI, as it was not medically and causally related to the work injury. He said the purpose of the injections here was to treat preexisting, noncompensable lumbar spondylosis and spondylolysis and the compensable injury was now beyond Rule 20 treatment guidelines. 3

Dr. Stoll also found no medical reason preventing Mr. Hankins from returning to his work duties. Dr. Stoll placed Mr. Hankins at maximum medical improvement (“MMI”) for the compensable sprain of ligaments of the lumbar spine and found 4% whole person impairment related to the compensable injury.

2 The previous IME report that Dr. Stoll referenced in his Addendum report was not included in the record below. 3 See W. Va. Code R. § 85-20 (2006). 2 The claim administrator issued two orders involved in this appeal on September 9, 2021. One order denied Dr. Crow’s request for the L5-S1 LESI injections based upon Dr. Stoll’s addendum report, because two of the three EMG/NCS tests were normal, and that treatment for a lumbar sprain was beyond the treatment guidelines of Rule 20. The second order suspended TTD benefits based on Dr. Stoll’s finding that Mr. Hankins could resume normal work duties.

Dr. Wisman, the treating physician in this claim, filed a Diagnosis Update dated September 13, 2021, requesting lumbar radiculopathy to be added as a compensable condition in the claim. The claim administrator denied the request in an order dated October 6, 2021, which is the third order at issue in this appeal. The order stated the denial of the diagnosis was based on the two normal EMG/NCS reports and Dr. Stoll’s report.

Dr. Wisman’s report dated October 27, 2021, said Mr. Hankins had a prior back injury in 2017, but it resolved in a week and caused no further issues until January 24, 2021. He also said he had no evidence that Mr. Hankins was treated for lumbar issues before his injury in 2017. Finally, Dr. Wisman stated that Dr. Crow indicated an acute L5- S1 nerve impingement was caused by the injury and recommended injections. Dr. Wisman expressed his support for the injections and said a “discreet [sic] new injury” had occurred.

In a decision entered on July 11, 2022, the OOJ affirmed the order dated October 6, 2021, which denied the compensability of lumbar radiculopathy. The decision also affirmed the two orders dated September 9, 2021, denying Dr. Crow’s request for L5-S1 LESI injections, and suspending TTD benefits.4 The decision found that Mr. Hankins failed to prove a diagnosis of radiculopathy, and failed to prove that the lumbar injection was medically related and reasonably required medical treatment for the compensable low back strain. The decision also found that Mr. Hankins did not prove he remained temporarily totally disabled as a result of the compensable injury.

The OOJ found that Dr. Wisman’s report reflected an incomplete understanding of Mr. Hankins’ medical history, which included a substantial evidentiary record of preexisting low back injuries and complaints. The decision pointed out that the only evidence supporting radiculopathy consisted of some of Dr. Wisman’s reports, the report of Dr. Crow, and one EMG/NCS report. The OOJ noted that Dr. Crow did not have the benefit of reviewing the EMG/NCS data before making his diagnosis. It also noted that Dr. Wisman incorrectly indicated that Dr. Crow found that the injury caused an acute L5-S1 nerve impingement. Instead, as the OOJ noted, Dr. Crow’s report suggested that the injections were related to disc degeneration and L5 radiculopathy.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

§ 23-4-3
West Virginia § 23-4-3
§ 23-5
West Virginia § 23-5
§ 51
West Virginia § 51

Cite This Page — Counsel Stack

Bluebook (online)
Dallas Hankins v. Sprouting Farms Corp., Counsel Stack Legal Research, https://law.counselstack.com/opinion/dallas-hankins-v-sprouting-farms-corp-wvactapp-2022.